The ART123 note says it has demonstrated efficacy in a pre-clinical MODEL - not a preclinical trial. I think this might be the source of confusion.
In other words, this stuff works on animals, but has not yet been tested on humans - that begins with the clinical safety trial.
It's a good announcement, as they now have another drug candidate to push through the process.
Trading in AAH has been difficult lately. I was very surprised with the fall after the EGX takeover - seems like a good fit for me. Perhaps they overpaid a little though.
I'm expecting not much to happen with the share price until they have a MAJOR announcement - e.g. a commercialisation deal, or a completion of Phase II trials. It will probably be a good idea to sell on any spike, as it will likely drift lower again afterwards. Very disappointing really.
- Forums
- ASX - By Stock
- trading
AAH
arana therapeutics limited
The ART123 note says it has demonstrated efficacy in a...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AAH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online